Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

LTGO

$13.513.15%-0.44

Latigo Biotherapeutics, Inc. Common Stock (LTGO)

Date: O: H: L: C: Vol:

Latigo Biotherapeutics, Inc. Common Stock Borsa (LTGO) Ultime notizie

A 19.9% stake in Latigo Biotherapeutics (LTGO) is reported by a Westlake fund leader. - Stock Titan

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK

Latigo Biotherapeutics, Inc. (NASDAQ:LTGO) Sees Large Growth in Short Interest - MarketBeat

Latigo Biotherapeutics (NASDAQ:LTGO) Stock Price Up 5.1% - Here's What Happened - MarketBeat

Latigo Biotherapeutics, Inc. Common Stock (NASDAQ: LTGO) Stock Price, News & Analysis - Kalkine

Latigo Biotherapeutics, Inc. Common Stock (NASDAQ: LTGO) Stock Price, News & Analysis - kalkine.ca

Latigo Biotherapeutics, Inc. Common Stock (LTGO) Earnings Reports & Dates - FXEmpire

Latigo Biotherapeutics Q2 Results: EPS loss narrows 24% YoY - scanx.trade

Goldman Sachs initiates Latigo Biotherapeutics stock with buy rating on pain drug potential - Investing.com

Latigo Biotherapeutics (LTGO) draws 4.45M-share stake from Deep Track - Stock Titan

Sanofi Converts Series B Preferred Stock and Convertible Note into Latigo Biotherapeutics Common Shares Following IPO - Kalkine Media

Latigo Biotherapeutics (LTGO) Stock Price, News & Analysis $LTGO - MarketBeat

Latigo Biotherapeutics Completes IPO and Updates Governance - TipRanks

Latigo Biotherapeutics (LTGO) On IPO And Trial Data Looks About Right Valued - Yahoo Finance

Latigo Biotherapeutics, Inc. Common Stock (LTGO) Historical Quotes - Nasdaq

Latigo Biotherapeutics (Nasdaq:LTGO) - Stock Analysis - Simply Wall Street

Latigo Biotherapeutics (NasdaqGS:LTGO) Stock Price - Simply Wall Street

Latigo Biotherapeutics, Inc. (LTGO) Company Information - Simply Wall Street

Latigo Biotherapeutics: LTGO Stock Price Quote & News - Robinhood

Latigo Biotherapeutics Prices Upsized $345.6 Million Initial Public Offering - quiverquant.com

Latham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering - Latham & Watkins LLP

Latigo Biotherapeutics prices $345.6M IPO at $18 per share By Investing.com - Investing.com Nigeria

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK

Latigo IPO raises nearly $350M for pain drug development - BioPharma Dive

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK

Latigo Biotherapeutics, Inc. (LTGO) Stock Price, News, Quote & History - Yahoo! Finance Canada

Latigo Biotherapeutics, Inc. (LTGO) stock price, news, quote and history - Yahoo Finance Singapore

Latigo Biotherapeutics, Inc. (LTGO) stock price, news, quote and history - Yahoo Finance UK

Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering - GlobeNewswire

Latigo Biotherapeutics prices $345.6M IPO at $18 per share - Investing.com

Latigo Biotherapeutics files for Nasdaq IPO at up to $18 per share - Investing.com

Upcoming & Recent IPO's - IPOs Calendar - Yahoo! Finance Canada

Latigo Biotherapeutics files for Nasdaq IPO at up to $18 per share - StreetInsider

Upcoming & Recent IPO's - IPOs Calendar - Yahoo Finance

Latigo Biotherapeutics files for $256M-$288M Nasdaq IPO - scanx.trade

Non-Opioid Developer Latigo Biotherapeutics Files for Up to $288M Float as Lead Drug Nears Phase 3 - Briefs Finance

Latigo Biotherapeutics Commences IPO Process For Pain Treatment Pipeline (Pending:LTGO) - Seeking Alpha

Pain drugmaker Latigo outlines plans to go public - BioPharma Dive

Latigo Biotherapeutics, Developer of Non‑Opioid Pain Medicines, Files for Nasdaq Global Select Market IPO - TradingView

Simile a LTGO

PHAR$12.734.09%

JBIO$13.930.92%

GLUE$10.631.21%